We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
US Physical Therapy
USPH
$1.21B
| $955K | 0.01% |
20,107
-6,006
| -23% | -$255K |
|
|
SCLN
727
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $945K | 0.01% |
106,605
+69,542
| +188% | +$554K |
|
728
BJ's Restaurants
BJRI
$1.47B
| $943K | 0.01% |
+18,698
| New | +$920K |
|
729
LivePerson
LPSN
$31.2M
| $937K | 0.01% |
6,102
+1,864
| +44% | +$315K |
|
730
Tidewater
TDW
$4.28B
| $928K | 0.01% |
+1,504
| New | +$1.34M |
|
731
Veeco
VECO
$3.07B
| $922K | 0.01% |
+30,170
| New | +$944K |
|
732
Stride
LRN
$3.39B
| $921K | 0.01% |
58,610
-169,541
| -74% | -$2.52M |
|
|
AMWD
733
DELISTED
American Woodmark
AMWD
| $919K | 0.01% |
+16,800
| New | +$771K |
|
|
ICA
734
DELISTED
EMPRESAS ICA, S.A. DE C.V. ADS (EA REPTG 4 ORD PART CERT)
ICA
| $911K | 0.01% |
279,421
-101,003
| -27% | -$392K |
|
|
CSS
735
DELISTED
CSS Industries, Inc.
CSS
| $908K | 0.01% |
30,110
-1,739
| -5% | -$49.8K |
|
736
Central Garden & Pet Co
CENT
$2.74B
| $891K | 0.01% |
112,890
+7,554
| +7% | +$56.2K |
|
737
Biogen
BIIB
$30.7B
| $887K | 0.01% |
+2,100
| New | +$828K |
|
|
ALR
738
DELISTED
AlerisLife Inc
ALR
| $880K | 0.01% |
19,824
-16,297
| -45% | -$614K |
|
739
Willis Towers Watson
WTW
$32B
| $878K | 0.01% |
+6,880
| New | +$844K |
|
|
BLT
740
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $861K | 0.01% |
+66,820
| New | +$1.03M |
|
|
NATI
741
DELISTED
National Instruments Corp
NATI
| $859K | 0.01% |
26,800
+3,001
| +13% | +$93.2K |
|
|
ATSG
742
DELISTED
Air Transport Services Group
ATSG
| $854K | 0.01% |
92,577
+21,209
| +30% | +$185K |
|
743
AMERISAFE
AMSF
$530M
| $851K | 0.01% |
+18,400
| New | +$779K |
|
744
Transportadora de Gas del Sur
TGS
$4.35B
| $836K | 0.01% |
162,971
-556,697
| -77% | -$2.11M |
|
745
Comtech Telecommunications
CMTL
$51.8M
| $835K | 0.01% |
28,848
-61,864
| -68% | -$2.02M |
|
|
SNR
746
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $835K | 0.01% |
50,183
-351,738
| -88% | -$5.93M |
|
747
Rockwell Automation
ROK
$48.7B
| $834K | 0.01% |
7,188
-35,403
| -83% | -$3.98M |
|
748
Methode Electronics
MEI
$585M
| $833K | 0.01% |
+17,700
| New | +$707K |
|
|
CVGW
749
DELISTED
Calavo Growers
CVGW
| $832K | 0.01% |
16,176
-1,817
| -10% | -$81.3K |
|
750
Badger Meter
BMI
$3.99B
| $831K | 0.01% |
27,744
| – | – |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.